New England Journal of Medicine Journal uri icon
Overview
publication venue for
  • Bronchodilators in tobacco-exposed persons with symptoms and preserved lung function 2022
  • Evaluation of acute adverse events after Covid-19 vaccination during pregnancy 2022
  • Early convalescent plasma for high-risk outpatients with Covid-19 2021
  • Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings 2021
  • Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine 2021
  • Cutaneous leishmaniasis 2020
  • Stolen breaths 2020
  • Metoprolol for the prevention of acute exacerbations of COPD 2019
  • Secondary surgical cytoreduction for recurrent ovarian cancer 2019
  • Vitamin D supplementation and prevention of type 2 diabetes 2019
  • Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC 2018
  • Effect of aspirin on all-cause mortality in the healthy elderly 2018
  • Effect of aspirin on cardiovascular events and bleeding in the healthy elderly 2018
  • Effect of aspirin on disability-free survival in the healthy elderly 2018
  • Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC 2018
  • Angiotensin II for the treatment of vasodilatory shock 2017
  • Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer 2017
  • Liraglutide and renal outcomes in type 2 diabetes 2017
  • Intensive blood-pressure lowering in patients with acute cerebral hemorrhage 2016
  • Liraglutide and cardiovascular outcomes in type 2 diabetes 2016
  • Structural racism and supporting black lives - the role of health professionals 2016
  • High-cost generic drugs--implications for patients and policymakers 2014
  • Alogliptin after acute coronary syndrome in patients with type 2 diabetes 2013
  • Threshold-based insulin-pump interruption for reduction of hypoglycemia 2013
  • Azithromycin for prevention of exacerbations of COPD 2011
  • Long-term effects of intensive glucose lowering on cardiovascular outcomes 2011
  • Lung volumes and emphysema in smokers with interstitial lung abnormalities 2011
  • Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes 2010
  • Effects of combination lipid therapy in type 2 diabetes mellitus 2010
  • Effects of intensive blood-pressure control in type 2 diabetes mellitus 2010
  • Effects of medical therapies on retinopathy progression in type 2 diabetes 2010
  • Effects of intensive glucose lowering in type 2 diabetes 2008
  • Executive physicals--bad medicine on three counts 2008
  • Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus 2003
  • Inventing a new model of hypertension care for black men [editorial].  378. 2018
  • Romosozumab versus Alendronate and fracture risk in women with osteoporosis [editorial].  378. 2018
  • Access to essential medicines in the United States [editorial].  375. 2016
  • Essential medicines in the United States--why access is diminishing [editorial].  374. 2016
  • High-cost generic drugs--implications for patients and policymakers [editorial].  372. 2015
  • Threshold insulin-pump interruption to reduce hypoglycemia [editorial].  369. 2013
  • Hypereosinophilic syndrome and mepolizumab [editorial].  358. 2008
  • Management of acute hip fracture [review] 2017
  • Clinical practice. Vertebral fractures [review] 2011